(redirected from Mycelex)
Also found in: Medical.
Related to Mycelex: clotrimazole


A broad-spectrum antifungal drug, C22H17ClN2, used topically to treat a variety of superficial fungal infections, including candidiasis and ringworm.

[c(h)lo(ro)- + tr(i)- (from its three phenyl groups) + im(id)azole.]


n clotrimazol m
References in periodicals archive ?
Significant switched drugs include loperamide (Imodium) for diarrhea (1988), clotrimazole (Lotrimin) for athlete's foot and jock itch (1989), permethrin (Nix) for head lice (1990), clotrimazole (Gyne-Lotrimin and Mycelex) for yeast infections (1990), famotidine (Pepcid AC) for acid indigestion (1995), nicotine polacrilex (Nicorette) for smoking cessation (1996), and loratadine (Claritin) for seasonal allergies (2002).
Mycelex 7 from Bayer's consumer care division's, thanks to
Dollar volume fell from $198.8 million to $176.2 million, according to Towne-Oller, with the top three brands--Advanced Care Products' Monistat 7, Schering-Plough Health-Care Product's Gyne-Lotrimin and Bayer's Mycelex 7--all experiencing reversals.
"Like the feminine vaginal itch and irritation category before Mycelex and Monistat switched to O-T-C status, the category is poised for significant growth.
He cited a product offering that now includes not only Bayer but also Alka-Seltzer, Midol, Phillips' Milk of Magnesia, One-A-Day and Mycelex - all of which place either first or second in sales in their respective categories.
36 Private ibuprofen tablets (200 mg.) 100s 41 Mycelex 7 cream 1.5 oz.
An important player in another segment of the sports medicine category is Miles Laboratories Inc., the maker of Mycelex topical antifungal products.
Also, several prescription to over-the-counter status switches, notably Schering-Plough Corp.'s Lotrimin AF and Miles Inc.'s Mycelex, have been well received says the foot care product buyer for Melville, N.Y.-based Genovese Drug Stores.
The most recent switch is Miles Inc.'s Mycelex. The anti-fungal was expected to be available on retailers' shelves in December.
John Siebert, vice president of research and development, says that Mycelex O-T-C, an antifungal medication, has just been approved by the FDA.